...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70) (vol 21, pg 2924, 2015)
【24h】

Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70) (vol 21, pg 2924, 2015)

机译:与AFATINIB和TRASTUZIMAB的双封闭式作为Neoadjuvant治疗,用于接受含有含有化疗-DAFNE(GBG-70)的含少炸蛋白 - 蒽环蛋白(GBG-70)的紫罗兰甘油(GBG-70)(第21卷,PG 2924,2015)

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号